Cited by 724Tryptophan and brain disordersGut microbiota and healthGastrointestinal motility and disorders

Kynurenine pathway metabolism and the microbiota-gut-brain axis

Open access
Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G.·2017·Neuropharmacology

Abstract

It has become increasingly clear that the gut microbiota influences not only gastrointestinal physiology but also central nervous system (CNS) function by modulating signalling pathways of the microbiota-gut-brain axis. Understanding the neurobiological mechanisms underpinning the influence exerted by the gut microbiota on brain function and behaviour has become a key research priority. Microbial regulation of tryptophan metabolism has become a focal point in this regard, with dual emphasis on the regulation of serotonin synthesis and the control of kynurenine pathway metabolism. Here, we focus in detail on the latter pathway and begin by outlining the structural and functional dynamics of the gut microbiota and the signalling pathways of the brain-gut axis. We summarise preclinical and clinical investigations demonstrating that the gut microbiota influences CNS physiology, anxiety, depression, social behaviour, cognition and visceral pain. Pertinent studies are drawn from neurogastroenterology demonstrating the importance of tryptophan and its metabolites in CNS and gastrointestinal function. We outline how kynurenine pathway metabolism may be regulated by microbial control of neuroendocrine function and components of the immune system. Finally, preclinical evidence demonstrating direct and indirect mechanisms by which the gut microbiota can regulate tryptophan availability for kynurenine pathway metabolism, with downstream effects on CNS function, is reviewed. Targeting the gut microbiota represents a tractable target to modulate kynurenine pathway metabolism. Efforts to develop this approach will markedly increase our understanding of how the gut microbiota shapes brain and behaviour and provide new insights towards successful translation of microbiota-gut-brain axis research from bench to bedside. This article is part of the Special Issue entitled 'The Kynurenine Pathway in Health and Disease'.

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2016.07.002

Cites

226 of 226 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Under inflammatory conditions, tryptophan metabolism shifts towards increased kynurenine levels, leading to an imbalance in downstream metabolites such as quinolinic acid and kynurenic acid.

    “Under inflammatory conditions, tryptophan metabolism shifts towards increased kynurenine levels, leading to an imbalance in its downstream metabolites (TRYCATs), such as quinolinic acid (QUIN) and kynurenic acid (KYNA).”
  • In the gut, tryptophan may be metabolized under direct or indirect control by the GM, producing compounds such as serotonin, kynurenines, tryptamine, and indolic compounds that participate in MGB communication.

    “In the gut, it may be further metabolized under direct or indirect control by the GM, giving rise to several compounds, such as serotonin, kynurenines, tryptamine, and indolic compounds, which participate in MGB communication (197, 198).”
  • Kynurenine can pass the blood-brain barrier and has been shown to produce neuroinflammation and neurodegeneration, which have also been reported in AD and depression.

    “Kynurenine, which can pass the blood-brain barrier, has been shown to produce neuroinflammation and neurodegeneration, which have also been reported in AD and depression [31].”
  • Many of these differences can be driven by a unique metabolic profile of each bacterial genus, including the production of different biologically active compounds, such as SCFAs or indoles.

    “Many of these differences can be driven by a unique metabolic profile of each bacterial genus, including the production of different biologically active compounds, such as SCFAs or indoles (Kennedy et al., 2017; Sandhu et al., 2017).”
  • More than 90% of tryptophan is catabolized down to kynurenine in the liver, with liver Tdo2 activity determining systemic kynurenine levels and tryptophan availability for the brain.

    “Indeed, > 90% of tryptophan is catabolized down to kynurenine in the liver, with liver Tdo2 activity determining the systemic levels of kynurenine, and the availability of tryptophan for the brain (Kennedy et al., 2017).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G.
Affiliations
University College Cork (IE)
Corresponding author
Clarke, G.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2017-01
Volume
112
Issue
Pt B
Pages
399-412
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2469798172
Cited by
724
References
226
Citations by year
2026: 78 · 2025: 81 · 2024: 106 · 2023: 93 · 2022: 82 · 2021: 83 · 2020: 72 · 2019: 47 · 2018: 45 · 2017: 28 · 2016: 9
FWCI
2.58
Type
journal article
Language
en
Open access
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-nd)
Funders
  • Brain and Behavior Research Foundation (20771)
  • National Alliance for Research on Schizophrenia and Depression
  • Seventh Framework Programme (613979, FFP7- KBBE/2013–2018)
  • Science Foundation Ireland (HRA-POR-2014-64, SFI/12/RC/2273)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
kynurenine pathway, gut microbiota, microbiota-gut-brain axis, tryptophan metabolism, serotonin synthesis, neuroendocrine regulation, anxiety, depression, social behavior, cognition, visceral pain, neurogastroenterology, immune system, microbiota-targeted therapy
MeSH terms
Gastrointestinal Microbiome, Animals, Brain, Humans, Kynurenine, Gastrointestinal Tract, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review